NewsBenzinga60 Degrees Pharmaceuticals presenterà i dati sull’analisi intermedia del suo studio clinico su tafenoquina il 6 ottobre 60 Degrees Pharmaceuticals presenterà i dati sull’analisi intermedia del suo studio clinico su tafenoquina il 6 ottobre Benzinga 2026.10.01 12:12 (GMT+0) Open on Benzinga Other news Microsoft Cost Cuts: What a 20% Reduction at Azure Could Mean for MSFT Stock Dow Jones Today: DJIA Flat as Oil Edges Lower; Tech Stocks Rebound - TipRanks.com Gas Never Used To Be This Pricey In October; West Coast Imports Are Surging Wells Fargo Maintains Equal-Weight on Sonoco Products, Lowers Price Target to $53 Piper Sandler Maintains Neutral on WaFd, Lowers Price Target to $31 INTC vs. AMD: Which AI Chip Stock Could Continue to Rally After Today? - TipRanks.com
